Skip to content

Products

NAVITI · International commercial advisory

Selected materials illustrate the commercial contexts encountered in NAVITI’s work. They are not a catalogue of medical or veterinary claims.

Portfolio index

Products are the starting point. Market context decides what follows.

A selected view of product and brand contexts encountered in international commercial work.

Human health · iron supplementation context

OmegaFer

An iron-supplement presentation combining haem and microencapsulated iron in a human-health portfolio context.

Human health · portfolio context

OmegaLactin

A MicroLactin-based human-health concept presented in capsule format for portfolio and market discussions.

Companion animal · mobility context

DoggieLactin

A companion-animal chewable-tablet concept positioned around mobility and joint-care category needs.

Veterinary · canine context

UrsoDoggie

A canine chewable-tablet concept framed for the muscle-health and mobility category.

Veterinary · feline context

UrsoKitty

A feline capsule concept framed for muscle-health, regeneration and mobility categories.

Oral care · portfolio context

Aperisan

A Dentinox oral-care concept built around a 3-in-1 Oral Flora+ portfolio and microbiome-focused positioning.

Pharmaceutical · historical context

Meptid

Historical professional material for a prescription injectable analgesic, shown only as pharmaceutical portfolio context.

Brand · international portfolio context

Dentinox International

Dentinox International is shown as an example of brand and portfolio context. Display does not imply current availability, endorsement or a product claim.

Shown for corporate and commercial context only. Product status, availability and regulatory classification vary by market. No medical or veterinary claims are made.

OmegaFer product presentation supplied to NAVITI
Reference image · supplied material

Product dossier · 01 · Human health · iron supplementation context

OmegaFer

A human-health iron presentation combining haem iron and microencapsulated iron in an enteric-capsule format, framed for international portfolio and market discussions.

The supplied presentation places OmegaFer in the iron-supplement category and brings two iron forms together within one capsule proposition.

The relevant NAVITI conversation is commercial: market fit, positioning, route to market and the requirements that must be confirmed before launch.

Presentation
30 enteric capsules
Material focus
Haem iron and microencapsulated iron; the supplied pack also references vitamins B12 and C and folate.
Commercial context
Human-health supplementation and cross-border portfolio assessment.

Information is presented only as corporate and commercial portfolio context. Product status, availability, composition and regulatory classification must be verified for each market.

Discuss this product context
OmegaLactin product presentation supplied to NAVITI
Reference image · supplied material

Product dossier · 02 · Human health · portfolio context

OmegaLactin

A human-health capsule presentation built around MicroLactin 500 mg, shown as a mobility and joint-health portfolio concept for commercial evaluation.

The supplied material presents OmegaLactin as a 120-capsule proposition within the human-health mobility category.

Commercial assessment may cover category fit, communication boundaries, channel strategy and the profile of an appropriate market partner.

Presentation
120 capsules
Material focus
MicroLactin 500 mg is referenced on the supplied presentation.
Commercial context
Human-health portfolio and market-development discussions.

Information is presented only as corporate and commercial portfolio context. Product status, availability, composition and regulatory classification must be verified for each market.

Discuss this product context
DoggieLactin product presentation supplied to NAVITI
Reference image · supplied material

Product dossier · 03 · Companion animal · mobility context

DoggieLactin

A canine chewable-tablet concept using MicroLactin, developed as a differentiated European portfolio proposition.

The supplied material presents a 120-tablet format and references 500 mg of MicroLactin per chewable tablet.

For international development, the focus is on companion-animal category fit, channel expectations and partner capability in each market.

Presentation
120 chewable tablets
Material focus
500 mg of MicroLactin per tablet is referenced in the supplied comparison.
Commercial context
Companion-animal mobility category and European partner development.

Information is presented only as corporate and commercial portfolio context. Product status, availability, composition and regulatory classification must be verified for each market.

Discuss this product context
UrsoDoggie product presentation supplied to NAVITI
Reference image · supplied material

Product dossier · 04 · Veterinary · canine context

UrsoDoggie

A canine chewable-tablet concept for muscle-health and mobility categories, centered on ursolic acid from rosemary extract.

The supplied leaflet presents UrsoDoggie in a 60-tablet format for the companion-animal portfolio.

Any market discussion should verify formulation, communication, veterinary classification, route to market and local regulatory requirements.

Presentation
60 chewable tablets
Material focus
The supplied leaflet references 24 mg of ursolic acid per tablet.
Portfolio context
A companion-animal concept intended for dogs.

Information is presented only as corporate and commercial portfolio context. Product status, availability, composition and regulatory classification must be verified for each market.

Discuss this product context
UrsoKitty product presentation supplied to NAVITI
Reference image · supplied material

Product dossier · 05 · Veterinary · feline context

UrsoKitty

A feline capsule concept for muscle-health, regeneration and mobility categories, centered on ursolic acid from rosemary extract.

The supplied leaflet presents UrsoKitty in a 60-capsule format for the companion-animal portfolio.

Commercial evaluation should verify formulation, communication, veterinary classification, channel fit and all market-specific requirements.

Presentation
60 capsules
Material focus
The supplied leaflet references 12 mg of ursolic acid per capsule.
Portfolio context
A companion-animal concept intended for cats.

Information is presented only as corporate and commercial portfolio context. Product status, availability, composition and regulatory classification must be verified for each market.

Discuss this product context
Aperisan oral-care portfolio presentation supplied to NAVITI
Reference image · supplied material

Product dossier · 06 · Oral care · portfolio context

Aperisan

A holistic oral-care platform organized around oral-flora balance and a five-format product architecture under the 3-in-1 Oral Flora+ concept.

The supplied concept is broader than one product: it develops a consistent portfolio story across daily-care and more focused oral-care formats.

Its commercial potential lies in coherent premium positioning, format architecture and communication adapted to retail and professional channels.

Portfolio
Toothpaste, toothpaste tablets, mouthwash, mouthwash concentrate and oral gel.
Material focus
The supplied concept repeatedly references Lactobacillus ferment and Acacia Senegal gum.
Commercial context
Premium oral-care positioning, retail activation and professional-channel communication.

Information is presented only as corporate and commercial portfolio context. Product status, availability, composition and regulatory classification must be verified for each market.

Discuss this product context
Historical MEPTID professional material supplied to NAVITI
Reference image · supplied material

Product dossier · 07 · Pharmaceutical · historical context

Meptid

Historical professional material for MEPTID 100 mg solution for injection (meptazinol), retained solely as pharmaceutical portfolio context for qualified discussions.

The supplied material describes a prescription injectable opioid analgesic intended for professional medical use.

Any discussion must begin with verification of current authorization, indication, professional audience, safety information and availability in the relevant market.

Presentation
The supplied material references 10 × 1 ml ampoules.
Category
Prescription injectable opioid analgesic for professional medical use.
Status
Availability, indication and regulatory classification must be verified for each market.

Professional pharmaceutical material only. This page is not prescribing information, medical advice or a statement of current market authorization.
Dentinox International brand presentation supplied to NAVITI
Reference image · supplied material

Product dossier · 08 · Brand · international portfolio context

Dentinox International

An established German family healthcare brand portfolio focused on babies, children and family care, shown as international brand and portfolio-development context.

The supplied corporate material presents a Berlin-based company with its own production and a portfolio spanning baby, child and family healthcare.

For NAVITI, the relevant perspective is international portfolio development: market adaptation, partner dialogue and disciplined brand stewardship.

Brand base
Berlin-based company with its own production, as presented in the supplied corporate material.
Portfolio
Baby health, child health, family care and age-specific oral-care concepts.
Commercial context
International portfolio development, market adaptation and partner dialogue.

Information is presented only as corporate and commercial portfolio context. Product status, availability, composition and regulatory classification must be verified for each market.

Discuss this product context

Start a conversation

Bring the market question. We will help frame the next move.

Contact NAVITI